Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 189

1.

The interplay between microbes and the immune response in inflammatory bowel disease.

Goethel A, Croitoru K, Philpott DJ.

J Physiol. 2018 Sep;596(17):3869-3882. doi: 10.1113/JP275396. Epub 2018 Jul 17.

PMID:
29806140
2.

Clinical and genetic risk factors for decreased bone mineral density in Japanese patients with inflammatory bowel disease.

Naito T, Yokoyama N, Kakuta Y, Ueno K, Kawai Y, Onodera M, Moroi R, Kuroha M, Kanazawa Y, Kimura T, Shiga H, Endo K, Nagasaki M, Masamune A, Kinouchi Y, Shimosegawa T.

J Gastroenterol Hepatol. 2018 Nov;33(11):1873-1881. doi: 10.1111/jgh.14149. Epub 2018 May 8.

PMID:
29603369
3.

Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease.

Chiba H, Kakuta Y, Kinouchi Y, Kawai Y, Watanabe K, Nagao M, Naito T, Onodera M, Moroi R, Kuroha M, Kanazawa Y, Kimura T, Shiga H, Endo K, Negoro K, Nagasaki M, Unno M, Shimosegawa T.

PLoS One. 2018 Mar 16;13(3):e0194036. doi: 10.1371/journal.pone.0194036. eCollection 2018.

4.

NOD2 and inflammation: current insights.

Negroni A, Pierdomenico M, Cucchiara S, Stronati L.

J Inflamm Res. 2018 Feb 12;11:49-60. doi: 10.2147/JIR.S137606. eCollection 2018. Review.

5.

Intestinal Epithelial Cell Autophagy Is Required to Protect against TNF-Induced Apoptosis during Chronic Colitis in Mice.

Pott J, Kabat AM, Maloy KJ.

Cell Host Microbe. 2018 Feb 14;23(2):191-202.e4. doi: 10.1016/j.chom.2017.12.017. Epub 2018 Jan 18.

PMID:
29358084
6.

NOD2 Suppresses Colorectal Tumorigenesis via Downregulation of the TLR Pathways.

Udden SMN, Peng L, Gan JL, Shelton JM, Malter JS, Hooper LV, Zaki MH.

Cell Rep. 2017 Jun 27;19(13):2756-2770. doi: 10.1016/j.celrep.2017.05.084.

7.

From sensing to shaping microbiota: insights into the role of NOD2 in intestinal homeostasis and progression of Crohn's disease.

Balasubramanian I, Gao N.

Am J Physiol Gastrointest Liver Physiol. 2017 Jul 1;313(1):G7-G13. doi: 10.1152/ajpgi.00330.2016. Epub 2017 Apr 27. Review.

8.

Genetics of inflammatory bowel disease: beyond NOD2.

Mirkov MU, Verstockt B, Cleynen I.

Lancet Gastroenterol Hepatol. 2017 Mar;2(3):224-234. doi: 10.1016/S2468-1253(16)30111-X. Epub 2017 Feb 9. Review.

PMID:
28404137
9.

rs2476601 polymorphism in PTPN22 is associated with Crohn's disease but not with ulcerative colitis: a meta-analysis of 16,838 cases and 13,356 controls.

Hedjoudje A, Cheurfa C, Briquez C, Zhang A, Koch S, Vuitton L.

Ann Gastroenterol. 2017;30(2):197-208. doi: 10.20524/aog.2017.0121. Epub 2017 Jan 5.

10.

Increased expression of IL12B mRNA transcribed from the risk haplotype for Crohn's disease is a risk factor for disease relapse in Japanese patients.

Kakuta Y, Kimura T, Negoro K, Kuroha M, Shiga H, Endo K, Kinouchi Y, Shimosegawa T.

J Gastroenterol. 2017 Dec;52(12):1230-1239. doi: 10.1007/s00535-017-1322-5. Epub 2017 Feb 22.

PMID:
28229296
11.

A functional variant of ATG16L2 is associated with Crohn's disease in the Chinese population.

Ma T, Wu S, Yan W, Xie R, Zhou C.

Colorectal Dis. 2016 Nov;18(11):O420-O426. doi: 10.1111/codi.13507.

PMID:
27611316
12.

Altered Prostasin (CAP1/Prss8) Expression Favors Inflammation and Tissue Remodeling in DSS-induced Colitis.

Keppner A, Malsure S, Nobile A, Auberson M, Bonny O, Hummler E.

Inflamm Bowel Dis. 2016 Dec;22(12):2824-2839.

13.

Association between MDR1 gene polymorphisms and the risk of Crohn's disease in a cohort of Algerian pediatric patients.

Bouzidi A, Mesbah-Amroun H, Boukercha A, Benhassine F, Belboueb R, Berkouk K, Messadi W, Touil-Boukoffa C.

Pediatr Res. 2016 Dec;80(6):837-843. doi: 10.1038/pr.2016.163. Epub 2016 Sep 7.

PMID:
27603561
14.

The genetic burden of inflammatory bowel diseases: implications for the clinic?

Gabbani T, Deiana S, Annese AL, Lunardi S, Annese V.

Expert Rev Gastroenterol Hepatol. 2016 Jun 9:1-9. [Epub ahead of print]

PMID:
27258545
15.

CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands.

Lamas B, Richard ML, Leducq V, Pham HP, Michel ML, Da Costa G, Bridonneau C, Jegou S, Hoffmann TW, Natividad JM, Brot L, Taleb S, Couturier-Maillard A, Nion-Larmurier I, Merabtene F, Seksik P, Bourrier A, Cosnes J, Ryffel B, Beaugerie L, Launay JM, Langella P, Xavier RJ, Sokol H.

Nat Med. 2016 Jun;22(6):598-605. doi: 10.1038/nm.4102. Epub 2016 May 9.

16.

Helminth infection promotes colonization resistance via type 2 immunity.

Ramanan D, Bowcutt R, Lee SC, Tang MS, Kurtz ZD, Ding Y, Honda K, Gause WC, Blaser MJ, Bonneau RA, Lim YA, Loke P, Cadwell K.

Science. 2016 Apr 29;352(6285):608-12. doi: 10.1126/science.aaf3229. Epub 2016 Apr 14.

17.

R-Spondins Are Expressed by the Intestinal Stroma and are Differentially Regulated during Citrobacter rodentium- and DSS-Induced Colitis in Mice.

Kang E, Yousefi M, Gruenheid S.

PLoS One. 2016 Apr 5;11(4):e0152859. doi: 10.1371/journal.pone.0152859. eCollection 2016.

18.

Mice lacking myosin IXb, an inflammatory bowel disease susceptibility gene, have impaired intestinal barrier function and superficial ulceration in the ileum.

Hegan PS, Chandhoke SK, Barone C, Egan M, Bähler M, Mooseker MS.

Cytoskeleton (Hoboken). 2016 Apr;73(4):163-79. doi: 10.1002/cm.21292. Epub 2016 Apr 4.

PMID:
26972322
19.

Identification of critical variants within SLC44A4, an ulcerative colitis susceptibility gene identified in a GWAS in north Indians.

Gupta A, Thelma BK.

Genes Immun. 2016 Mar;17(2):105-9. doi: 10.1038/gene.2015.53. Epub 2016 Jan 7.

PMID:
26741288
20.

Immunopathogenesis of IBD: current state of the art.

de Souza HS, Fiocchi C.

Nat Rev Gastroenterol Hepatol. 2016 Jan;13(1):13-27. doi: 10.1038/nrgastro.2015.186. Epub 2015 Dec 2. Review.

PMID:
26627550

Supplemental Content

Loading ...
Support Center